Prevalence, Incidence, and Factors Associated with Posttraumatic Stress at Three-Month Follow-Up among New York City Healthcare Workers after the First Wave of the COVID-19 Pandemic.
COVID-19
acute stress
healthcare worker
mental health
posttraumatic stress
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
27 12 2021
27 12 2021
Historique:
received:
16
11
2021
revised:
21
12
2021
accepted:
23
12
2021
entrez:
11
1
2022
pubmed:
12
1
2022
medline:
14
1
2022
Statut:
epublish
Résumé
Prevalence, incidence, and factors associated with posttraumatic stress disorder (PTSD) symptoms at follow-up among healthcare workers after the first wave of the COVID-19 pandemic are unknown. A web survey invitation was sent to healthcare worker listservs at a NYC medical center (April, 2020). The Primary Care (PC)-PTSD questionnaire was used to screen for PTSD symptoms at baseline and then every 2 weeks for 10 weeks. Incidence and prevalence of PTSD symptoms were determined at each time point. Multivariable generalized estimating equation models were performed to investigate the factors associated with a positive PC-PTSD screen at follow-up. Median age (interquartile range) of N = 230 participants was 36 (31-48) years; 79.6% were women; 82.6% worked in COVID-19-focused settings. The prevalence of PTSD symptoms decreased from 55.2% at baseline to 25.0% at 10 weeks ( PTSD symptoms improved over 3 months following the first wave of the COVID-19 pandemic. However, one out of four NYC healthcare workers still had an increased risk for PTSD at 10-weeks. Screening healthcare workers for PTSD symptoms should be considered during the COVID-19 pandemic.
Sections du résumé
BACKGROUND
Prevalence, incidence, and factors associated with posttraumatic stress disorder (PTSD) symptoms at follow-up among healthcare workers after the first wave of the COVID-19 pandemic are unknown.
METHODS
A web survey invitation was sent to healthcare worker listservs at a NYC medical center (April, 2020). The Primary Care (PC)-PTSD questionnaire was used to screen for PTSD symptoms at baseline and then every 2 weeks for 10 weeks. Incidence and prevalence of PTSD symptoms were determined at each time point. Multivariable generalized estimating equation models were performed to investigate the factors associated with a positive PC-PTSD screen at follow-up.
RESULTS
Median age (interquartile range) of N = 230 participants was 36 (31-48) years; 79.6% were women; 82.6% worked in COVID-19-focused settings. The prevalence of PTSD symptoms decreased from 55.2% at baseline to 25.0% at 10 weeks (
CONCLUSIONS
PTSD symptoms improved over 3 months following the first wave of the COVID-19 pandemic. However, one out of four NYC healthcare workers still had an increased risk for PTSD at 10-weeks. Screening healthcare workers for PTSD symptoms should be considered during the COVID-19 pandemic.
Identifiants
pubmed: 35010524
pii: ijerph19010262
doi: 10.3390/ijerph19010262
pmc: PMC8750525
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NHLBI NIH HHS
ID : K23 HL141682
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL141494
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL146911
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL146636
Pays : United States
Références
J Affect Disord. 2021 Feb 1;280(Pt B):1-6
pubmed: 33220632
JAMA Netw Open. 2020 Dec 1;3(12):e2028111
pubmed: 33284339
Int J Environ Res Public Health. 2021 Sep 20;18(18):
pubmed: 34574811
JAMA Netw Open. 2020 Dec 1;3(12):e2027935
pubmed: 33275156
J Psychiatr Res. 2007 Jan-Feb;41(1-2):119-30
pubmed: 16460760
Gen Hosp Psychiatry. 2020 Sep - Oct;66:1-8
pubmed: 32590254
Emerg Infect Dis. 2006 Dec;12(12):1924-32
pubmed: 17326946
Trials. 2020 Oct 21;21(1):870
pubmed: 33087178
Front Psychol. 2021 Dec 03;12:760678
pubmed: 34925163
Psychiatry Res. 2020 Aug;290:113130
pubmed: 32497969
Acad Emerg Med. 2021 Mar;28(3):314-324
pubmed: 33492755
Am J Physiol Regul Integr Comp Physiol. 2015 Aug 15;309(4):R315-21
pubmed: 26062635
J Affect Disord. 2021 Mar 1;282:527-538
pubmed: 33433382
JAMA Netw Open. 2020 Mar 2;3(3):e203976
pubmed: 32202646
Neuropsychopharmacology. 2003 Sep;28(9):1656-65
pubmed: 12838270
Am Fam Physician. 2003 Dec 15;68(12):2401-8
pubmed: 14705759
Int J Environ Res Public Health. 2020 Dec 05;17(23):
pubmed: 33291511
JAMA Netw Open. 2020 Feb 5;3(2):e1920476
pubmed: 32022879
N Engl J Med. 2020 Aug 6;383(6):510-512
pubmed: 32283003
J Occup Environ Med. 2018 Feb;60(2):126-131
pubmed: 29065061
Front Psychiatry. 2020 Apr 14;11:306
pubmed: 32346373
Arch Gen Psychiatry. 2008 Apr;65(4):431-7
pubmed: 18391131
Circulation. 2015 Jul 28;132(4):251-9
pubmed: 26124186